Filing Details

Accession Number:
0001209191-23-045653
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-14 16:41:20
Reporting Period:
2023-08-11
Accepted Time:
2023-08-14 16:41:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576263 Mirati Therapeutics Inc. MRTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352620 Faheem Hasnain C/O Mirati Therapeutics Inc.
3545 Cray Court
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-11 10,791 $27.80 10,791 No 4 P Indirect By Hasnain Revocable Trust Dated 2-19-2010
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Hasnain Revocable Trust Dated 2-19-2010
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 15,050 Direct